BusinessInspireMD Announces Fourth Quarter and Year-End 2017 Results; CGuard™ EPS Fourth Quarter Sales Increase 211% Versus Same Period Last yearBy Nasdaq OMXFeb 14, 2018, 12:30 PM UTC
BusinessInspireMD's CGuard Embolic Prevention System Featured in a Second Live Case Transmission at LINC 2018 by Leading Interventional CardiologistsBy Nasdaq OMXJan 31, 2018, 1:31 PM UTC
BusinessInspireMD’s CGuard™ Embolic Prevention System Featured in Successful Live Case Transmissions at LINC 2018 by Leading Vascular SurgeonsBy Nasdaq OMXJan 30, 2018, 1:19 PM UTC
BusinessInspireMD’s CGuard Embolic Prevention System to be Prominently Featured in Two Live Case Transmissions at LINC 2018By Nasdaq OMXJan 26, 2018, 3:11 PM UTC
BusinessInspireMD Announces Publication of an Independent Imaging Study Highlighting the Advantages of CGuard EPS Compared to Another Next Generation Carotid StentBy Nasdaq OMXJan 19, 2018, 3:18 PM UTC
BusinessInspireMD’s CGuard EPS Demonstrates Improved Outcomes over Carotid Endarterectomy in 50 Patient Comparative Study; Preliminary Results Featured at the 7th Munich Vascular Conference 2017By Nasdaq OMXDec 7, 2017, 5:23 PM UTC
BusinessInspireMD Announces Preliminary 2 Year Follow-up Results from the PARADIGM Clinical Study Using CGuard™ EPSBy Nasdaq OMXDec 5, 2017, 6:00 PM UTC
BusinessInspireMD Announces Expansion of its Distribution Network for CGuard™ EPS in Australia, New Zealand and VietnamBy Nasdaq OMXDec 4, 2017, 2:45 PM UTC
